Constipation resident survival guide: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 203: Line 203:
{{familytree  | | | | | | | | E01 | | | | | | | | | | | | | |E01=<div style="float: left; text-align: left; width: 25em; padding:1em;">❑ Adjust or discontinue medications causing constipation<br>
{{familytree  | | | | | | | | E01 | | | | | | | | | | | | | |E01=<div style="float: left; text-align: left; width: 25em; padding:1em;">❑ Adjust or discontinue medications causing constipation<br>
----
----
❑ Administer a trial of fiber and/or laxatives<br>
❑ Administer a trial of fiber and/or osmotic or stimulant laxatives<br>
----
----
'''Secondary constipation:'''<br>
'''If secondary causes of constipation are uncovered during evaluation:'''<br>
❑ Consider treating constipation due [[Constipation causes#Causes by Organ System|secondary causes]] if uncovered during evaluation (due to metabolic conditions, myopathies, neuropathies, or other conditions)
Due to metabolic conditions, myopathies, neuropathies, or other conditions<br>
:❑ Treat the secondary cause
❑ Treat the [[Constipation causes#Causes by Organ System|secondary cause]]<br>
'''or'''
'''or'''<br>
:Symptomatic treatment<br>
Offer symptomatic treatment<br>
----  
----  
'''Organic constipation:'''<br>
'''If organic causes of constipation are uncovered during evaluation:'''<br>
❑ Consider treating constipation due to organic causes if uncovered during evaluation (due to mechanical obstruction or adverse drug effect)
Due to mechanical obstruction or adverse drug effect<br>
:❑ Treat the organic cause
❑ Treat mechanical obstruction or remove the drug causing constipation<br>
'''or'''
'''or'''<br>
:Symptomatic treatment<br>
Offer symptomatic treatment<br>
----
----
'''[[Irritable bowel syndrome history and symptoms#Diagnostic Criteria|Irritable bowel syndrome:]]'''
'''If [[Irritable bowel syndrome history and symptoms#Diagnostic Criteria|irritable bowel syndrome]] is diagnosed during evaluation:'''
Consider treating [[Irritable bowel syndrome medical therapy|irritable bowel syndrome]]</div>}}
Treat [[Irritable bowel syndrome medical therapy|irritable bowel syndrome]]</div>}}
{{familytree  | | | | |,|-|-|-|^|-|-|-|.| | | | | | | | | | |}}
{{familytree  | | | | |,|-|-|-|^|-|-|-|.| | | | | | | | | | |}}
{{familytree  | | | | F01 | | | | | | F02 | | | | | | | | | |F01=Adequate response to trial of fiber and/or laxatives|F02=Inadequate response to trial of fiber and/or laxatives}}
{{familytree  | | | | F01 | | | | | | F02 | | | | | | | | | |F01=Adequate response to trial of fiber and/or laxatives|F02=Inadequate response to trial of fiber and/or laxatives}}
Line 260: Line 260:
----
----
'''Add hyperosmolar agents:'''<br>
'''Add hyperosmolar agents:'''<br>
❑ [[Polyethylene glycol]]: 8-32 oz once daily
❑ [[Polyethylene glycol]]: 8-32 oz OD
:❑ 2 weeks to 24 months
:❑ 2 weeks to 24 months
:❑ Polyethylene glycol with electrolyte containing preparation indicated when large volume is used for colonic cleansing <br>
:❑ Polyethylene glycol with electrolyte containing preparation indicated when large volume is used for colonic cleansing <br>
Line 270: Line 270:
❑ [[Bisacodyl]]
❑ [[Bisacodyl]]
:❑ 10 mg suppositories<br> '''or''' <br>
:❑ 10 mg suppositories<br> '''or''' <br>
:❑ 5-10 mg orally up to 3 times/week<br> '''or''' <br>
:❑ 5-10 mg orally up to 3 times/week<br>
'''or''' <br>
❑ [[Glycerin]]: Suppository OD <br>
❑ [[Glycerin]]: Suppository OD <br>
❑ [[Anthraquinones]]
❑ [[Anthraquinones]]
Line 287: Line 288:
{{familytree  | | | | | A01 | | | | | | | | | | | | | | A01= '''Normal or slow transit constipation'''}}
{{familytree  | | | | | A01 | | | | | | | | | | | | | | A01= '''Normal or slow transit constipation'''}}
{{familytree  | | | | | |!| | | | | | | | | | | | | | |}}
{{familytree  | | | | | |!| | | | | | | | | | | | | | |}}
{{familytree  | | | | | B01 | | | | | | | | | | | | | | B01=<div style="float: left; text-align: left; height: 24em; width: 17em; padding:1em;">'''Fiber'''<br>
{{familytree  | | | | | B01 | | | | | | | | | | | | | | B01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Administer:'''<br>
----
----
❑ [[Psyllium]]: 1 tsp up to 3 times daily  <br> '''OR''' <br>
❑ Hyperosmolar agents
❑ [[Methylcellulose]]: 1 tsp up to 3 times daily<br>'''OR''' <br>
:❑ [[Polyethylene glycol]]: 8-32 oz OD<br>
❑ [[Calcium polycarbophil]]: 2-4 tablets OD  <br>
'''or'''<br>
Insoluble fiber (wheat bran) is not preferred <br>
❑ Saline laxatives
:❑ [[Milk of magnesia]]: 15-30 mL OD or BID<br>
'''or'''<br>
❑ Stimulant laxatives
:❑ [[Bisacodyl]]
::❑ 10 mg suppositories<br> '''or''' <br>
::5-10 mg orally up to 3 times/week</div>}}
{{familytree  | | | |,|-|^|-|.| | | | | | | | | | | | | }}
{{familytree  | | | C01 | | C02 | | | | | | | | | | | | C01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Patient improves'''<br>
----
----
'''PLUS'''
❑ Continue the same regimen on a long term basis</div>|C02=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Patient does not improve'''<br>
----
----
'''Saline laxative'''<br>
❑ Modify the treatment regimen by considering<br>
:❑ Secretagogues
::❑ Lubiprostone 24 μg BID <br> '''or''' <br>
::❑ Linaclotide 145 μg daily<br>
'''or'''<br>
:❑ Serotonin 5-HT4 receptor agonists
::❑ Prucalopridec</div>}}
{{familytree  | | | | | |,|-|^|-|.| | | | | | | | | | | }}
{{familytree  | | | | | D01 | | D02 | | | | | | | | | |D01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Patient improves'''<br>
----
----
[[Milk of magnesia]]: 15-30 ml OD or BID <br></div>}}
Continue the same regimen on a long term basis</div>|D02=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Patient does not improve'''<br>
{{familytree  | | | | | |!| | | | | | | | | | | | | | |}}
{{familytree  | | | | | C01 | | | | | | | | | | | | | | C01= Response to treatment}}
{{familytree  | | |,|-|-|^|-|-|.| | | | | | | | | | | |}}
{{familytree  | | D01 | | | | D02 | | | | | | | | | | | D01=Yes | D02=No}}
{{familytree  | | |!| | | | | |!| | | | | | | | | | | |}}
{{familytree  | | E01 | | | | E02 | | | | | | | | | | | E01= Continue the same regimen| E02=<div style="float: left; text-align: left; height: 10em; width: 14em; padding:1em;">'''Add stimulant laxative'''<br>
----
----
[[Bisacodyl]]: 10 mg suppositories or 5-10 mg orally up to 3 times/wk  <br> '''OR''' <br>
Repeat colonic transit test while continuing medications</div> }}
❑ [[Glycerin]]: Suppository OD</div>}}
{{familytree  | | | | | | | |,|-|^|-|.| | | | | | | | | }}
{{familytree  | | | | | | | | |!| | | | | | | |}}
{{familytree  | | | | | | | E01 | | E02 | | | | | | | E01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Delayed transit'''<br>
{{familytree  | | | | | | | | F01 | | | | | | | F01=Response to treatment}}
{{familytree  | | | | | |,|-|-|^|-|-|.| | | | |}}
{{familytree  | | | | | G01 | | | | G02 | | | | G02=Yes| G01=No}}
{{familytree  | | | | | |!| | | | | |!| | | | |}}
{{familytree  | | | | | H01 | | | | H02 | | | |H02=Continue the same regimen| H01=<div style="float: left; text-align: left; height: 10em; width: 14em; padding:1em;">'''Add hyperosmolar agents'''<br>
----
----
[[PEG]]: 8-32 oz once daily  <br> '''OR''' <br>
Consider gastric emptying</div>|E02=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Normal transit'''<br>
❑ [[Lactulose]]: 15-30 ml OD or BID</div>}}
{{familytree  | | | | | |!| | | | | | | |}}
{{familytree  | | | | | I01 | | | | | | | | |I01= Response to treatment}}
{{familytree  | | |,|-|-|^|-|-|.| | | | | | | |}}
{{familytree  | | J01 | | | | J02 | | | | | | |J01=Yes| J02=No}}
{{familytree  | | |!| | | | | |!| | | | |}}
{{familytree  | | H01 | | | | H02 | | | |H01=Continue the same regimen|H02=Adjust and change medications periodically}}
{{familytree  | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree/end}}
 
===Slow Transit Constipation===
{{Family tree/start}}
{{familytree  | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree  | | | | | A01 | | | | | | | | | | | | | | A01= '''Slow transit constipation'''}}
{{familytree  | | | | | |!| | | | | | | | | | | | | | |}}
{{familytree  | | | | | B01 | | | | | | | | | | | | | | B01=<div style="float: left; text-align: left; height: 26em; width: 17em; padding:1em;">'''Fiber'''<br>
----
----
[[Psyllium]]: 1 tsp up to 3 times daily  <br> '''OR''' <br>
Adjust medications as needed</div>}}
❑ [[Methylcellulose]]: 1 tsp up to 3 times daily<br>
{{familytree  | | | | |,|-|-|^|-|-|.| | | | | | | | | | }}
{{familytree  | | | | F01 | | | | F02 | | | | | | | | | |F01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Slow emptying'''<br>
----
----
'''PLUS'''
❑ Consider assessment for upper GI motility disorder</div>|F02='''Normal emptying''' }}
{{familytree  | | |,|-|^|-|.| | | |!| | | | | | | | | |}}
{{familytree  | | G01 | | G02 |-| G03 | | | | | | | |G01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Abnormal'''<br>
----
----
'''Saline laxative'''<br>
❑ Manage the upper GI motility disorder appropriately</div>|G02='''Normal'''|G03=Consider colonic manometry ± barostat}}
{{familytree  | | | | | | | | |,|-|^|-|.| | | | | | | |}}
{{familytree  | | | | | | | | H01 | | H02 | | | | | | |H01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Normal'''<br>
----
----
[[Milk of magnesia]]: 15-30 ml OD or BID <br>
Consider temporary loop ileostomy</div>|H02=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Abnormal'''<br>
----
----
'''PLUS'''
Consider subtotal colectomy + ileorectal anastamosis</div>}}  
----
{{familytree/end}}
'''Stimulant laxative'''<br>
 
----
===Defecatory disorder===
[[Bisacodyl]]: 10 mg suppositories or 5-10 mg orally up to 3 times/wk </div>}}
{{Family tree/start}}
{{familytree   | | | | | |!| | | | | | | | | | | | | | |}}
{{familytree  | | | | | | | | | | | | | | | | | | | | | | | | | }}
{{familytree  | | | | | C01 | | | | | | | | | | | | | | C01= Response to treatment}}
{{familytree  | | | | | | | | A01 | | | | | | | | | | | | | | A01=<div style="float: left; text-align: left; width: 17em; padding:1em;">Chronic constipation who have not responded to a high-fiber diet and/or over-the-counter laxatives after organic disorders have been excluded </div>}}
{{familytree  | | |,|-|-|^|-|-|.| | | | | | | | | | | |}}
{{familytree  | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{familytree  | | D01 | | | | D02 | | | | | | | | | | | D01=Yes | D02=No}}
{{familytree  | | | | | | | | A01 | | | | | | | | | | | | | | A01=<div style="float: left; text-align: left; width: 17em; padding:1em;">'''Order specific tests:'''<br>
{{familytree  | | |!| | | | | |!| | | | | | | | | | | |}}
------------
{{familytree  | | E01 | | | | E02 | | | | | | | | | | | E01= Continue the initial therapeutic regimen <br>❑ [[Fiber]] <br>❑ [[milk of magnesia]]| E02=<div style="float: left; text-align: left; height: 9em; width: 14em; padding:1em;">'''Add hyperosmolar agent'''<br>
❑ [[Constipation other imaging findings#Rectal Balloon Expulsion Test|Rectal Balloon Expulsion Test (BET)]] <br>
----
❑ [[Constipation other imaging findings#Anorectal Function Tests|Anorectal Manometry (ARM)]]<br>
❑ [[PEG]]: 8-32 oz once daily  <br> '''OR''' <br>
❑ [[Constipation other imaging findings#Defecography|Barium, Scintigraphic, and Magnetic Resonance Defecography (BD)]]  <br>
❑ [[Lactulose]]: 15-30 ml OD or BID</div>}}
❑ [[Constipation other imaging findings#Colorectal Transit Study|Colonic Transit Test (CTT)]] <br> </div>}}
{{familytree  | | | | | | | | |!| | | | | | | |}}
{{familytree  | | |,|-|-|-|v|-|^|-|v|-|-|-|.| | | | | | | | | | | |}}
{{familytree  | | | | | | | | F01 | | | | | | | F01=Response to treatment}}
{{familytree  | | A01 | | A02 | | A03 | | A04 | | | | | | | | A01= Normal BET, ARM, BD, CTT| A02=Abnormal CTT<br>Normal BET, ARM, BD |A03= Abnormal BET, ARM, BD <br> Normal CTT| A04= Abnormal BET, ARM, BD, CTT}}
{{familytree  | | | | | |,|-|-|^|-|-|.| | | | |}}
{{familytree  | | |!| | | |!| | | |!| | | |!| | | | | | | |}}
{{familytree  | | | | | G01 | | | | G02 | | | | G02=Yes| G01=No}}
{{familytree  | | A01 | | A02 | | A03 | | A04 | | | | | | | | A01=Normal transit constipation| A02=Slow transit constipation| A03=Pelvic floor dysfunction| A04= Combined slow transit constipation and pelvic floor dysfunction}}
{{familytree  | | | | | |!| | | | | |!| | | | |}}
{{familytree  | | | | | H01 | | | | H02 | | | |H02=Continue the initial therapeutic regimen| H01=Repeat colonic transit test with medications}}
{{familytree  | | | | | |!| | | | | | | |}}
{{familytree  | | | | | I01 | | | | | | | | |I01= Response to treatment}}
{{familytree  | | |,|-|-|^|-|-|.| | | | | | | |}}
{{familytree  | | J01 | | | | J02 | | | | | | |J01=Normal | J02=Delayed}}
{{familytree  | | |!| | | | | |!| | | | |}}
{{familytree  | | H01 | | | | H02 | | | |H01=Adjust medications as needed |H02=Repeat BET and BD}}
{{familytree  | | | | | |,|-|-|^|-|-|.| | | | | | | |}}
{{familytree  | | | | | I01 | | | | I02 | | | | | | | | I01=Normal | I02= Abnormal}}
{{familytree  | | | | | |!| | | | | |!| | | | |}}
{{familytree  | | | | | J01 | | | | J02 | | | | | | | |J01=Consider illeo rectal anastamosis or [[colectomy|subtotal colectomy]] | J02= Manage for pelvic floor dysfunction}}
{{familytree  | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree  | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree/end}}
{{familytree/end}}
Line 479: Line 462:
{{familytree  | H01 | | | | | | |H01=Consider surgery if no improvement}}
{{familytree  | H01 | | | | | | |H01=Consider surgery if no improvement}}
{{familytree/end}}
{{familytree/end}}
===Defecatory disorder===
{{Family tree/start}}
{{familytree  | | | | | | | | | | | | | | | | | | | | | | | | | }}
{{familytree  | | | | | | | | A01 | | | | | | | | | | | | | | A01=<div style="float: left; text-align: left; width: 17em; padding:1em;">Chronic constipation who have not responded to a high-fiber diet and/or over-the-counter laxatives after organic disorders have been excluded </div>}}
{{familytree  | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{familytree  | | | | | | | | A01 | | | | | | | | | | | | | | A01=<div style="float: left; text-align: left; width: 17em; padding:1em;">'''Order specific tests:'''<br>
------------
❑ [[Constipation other imaging findings#Rectal Balloon Expulsion Test|Rectal Balloon Expulsion Test (BET)]] <br>
❑ [[Constipation other imaging findings#Anorectal Function Tests|Anorectal Manometry (ARM)]]<br>
❑ [[Constipation other imaging findings#Defecography|Barium, Scintigraphic, and Magnetic Resonance Defecography (BD)]]  <br>
❑ [[Constipation other imaging findings#Colorectal Transit Study|Colonic Transit Test (CTT)]] <br> </div>}}
{{familytree  | | |,|-|-|-|v|-|^|-|v|-|-|-|.| | | | | | | | | | | |}}
{{familytree  | | A01 | | A02 | | A03 | | A04 | | | | | | | | A01= Normal BET, ARM, BD, CTT| A02=Abnormal CTT<br>Normal BET, ARM, BD |A03= Abnormal BET, ARM, BD <br> Normal CTT| A04= Abnormal BET, ARM, BD, CTT}}
{{familytree  | | |!| | | |!| | | |!| | | |!| | | | | | | |}}
{{familytree  | | A01 | | A02 | | A03 | | A04 | | | | | | | | A01=Normal transit constipation| A02=Slow transit constipation| A03=Pelvic floor dysfunction| A04= Combined slow transit constipation and pelvic floor dysfunction}}
{{familytree  | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree/end}}


==Do's==
==Do's==

Revision as of 20:50, 18 February 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]

Definition

Constipation is a syndrome that is characterized by difficulty in passing stool, by infrequent bowel movements, by hard stool, or by a feeling of incomplete evacuation that occurs either in isolation or secondary to another underlying disorder.[1][2][3]

Clinical subgroups Definitions
Normal transit constipation Normal transit constipation refers to constipation in patients with normal anorectal function and normal colonic transit, with or without abnormal colonic motor disturbances and abnormal (ie, reduced or increased) colonic sensations.
Slow transit constipation Slow transit constipation refers to constipation in patients with normal anorectal function but slow colonic transit, with or without abnormal colonic motor disturbances and abnormal (ie, reduced or increased) colonic sensations.
Defecatory disorders
(Outlet obstruction, obstructed defecation, dyschezia, anismus, or pelvic floor dyssynergia)
Defecatory disorders refer to constipation in patients with impaired rectal evacuation from inadequate rectal propulsive forces and/or increased resistance to evacuation during defecation, with or without structural disturbances like rectocele and intussusception, reduced rectal sensation, and slow colonic transit. Increased resistance to evacuation might follow high anal resting pressure (anismus) and/or incomplete relaxation or paradoxical contraction of the pelvic floor and external anal sphincters (dyssynergia).
Combination disorders Combination disorders refer to patients with combination or overlap of disorders (eg, STC with defecatory disorders), perhaps even an association with features of irritable bowel syndrome.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Management

Diagnostic Approach

Shown below is an algorithm depicting the diagnostic approach of constipation in adults based on the American Gastroenterological Association (AGA) guideline.[1][6]

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characterize the symptoms:

Symptoms suggestive of constipation:


❑ Difficulty in passing stool

❑ Desire to defecate but an inability to pass stool
❑ Straining to begin and/or to end defecation
❑ Prolongation in time to pass stool
❑ Sensation of incomplete emptying of bowel
❑ Sensation of anal blockage during defecation
❑ Difficulty in passing soft stool and/or enema fluid
❑ Difficulty in passing stool postprandial
❑ Direct digital manipualtion to pass stool
❑ Perineal or vaginal pressure to pass stool
❑ Sudden or gradual in onset
❑ ≥3 months

❑ Infrequency in passing stool
❑ Hard or lumpy stools
❑ Use of laxatives to pass stool

❑ Type of laxative
❑ Frequency of usage
❑ Dosage

❑ Use of enemas to pass stool
❑ Use of suppositories to pass stool


Symptoms associated with constipation:


Abdominal pain or abdominal discomfort:

❑ Associated with change in frequency of stool
❑ Associated with change in consistency of stool
❑ Improves with passage of stool
❑ During straining
❑ Persisting between bowel movements

Abdominal distention
Abdominal bloating
Diarrhea alternating with constipation
❑ Blood in stools
Fever
Nausea and vomiting
Loss of appetite
Loss of weight
Fatigue
Malaise
Fibromyalgia
❑ Psychosocial distress


Obtain a detailed history:


❑ Diet:

Dietary pattern change
Low fiber diet
Food intolerance
Medications:

❑ Systemic illness:

Diabetes
Hypothyroidism
❑ Gastrointestinal disorders
❑ Neuromuscular disorders

❑ Surgical history:

❑ Abdominal surgeries
Caesarean section
❑ Post surgical extended bed rest

❑ Trauma history: Spinal cord injury
❑ Family history:

Colorectal cancer
Pelvic masses
❑ Neuromuscular diseases

❑ Personal history:

Smoking cessation
Drug abuse
❑ Travel history
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient:

❑ General examination:

Pulse rate
Blood pressure
Respiratory rate
Weight
Thyroid
Signs of dehydration

❑ Perineal/rectal examination:

❑ Observe perianal skin for evidence of fecal soiling
❑ During stimulated evacuation observe
❑ Anal verge for any patulous opening or prolapse of anorectal mucosa
❑ Descent of the perineum
❑ During a squeeze aimed at retention observe the elevation of perineum
❑ Test anal reflex by a light pinprick or scratch
❑ During digital evaluation
❑ Evaluate the resting tone of the sphincter
❑ Look for puborectalis muscle tenderness
❑ Look for rectocele, hemorrhoids or anal fissure

❑ Abdominal examination:

Abdominal mass
Abdominal distension
Abdominal tenderness
Increased or decreased bowel sounds

❑ Neurological examination:

Neuropathy
Parkinson's disease
Spinal cord injury
Cerebrovascular disease
Depression
❑ Cognitive impairment

❑ Cardiovascular examination:

❑ Cardiac diseases

❑ Respiratory examination

❑ Chronic respiratory diseases

❑ Skeletal examination

❑ Degenerative joint diseases
❑ Immobility
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Order laboratory tests:

CBC
BMP
TSH
Serum calcium
Serum magnesium


When secondary causes are suspected:
❑ Further assessment for secondary causes of constipation (due to metabolic conditions, myopathies, neuropathies, or other conditions)


Consider structural evaluation of the colon:
For patients with clinically alarming symptoms and who have not undergone an age appropriate colon cancer screening procedure proceed with
Colonoscopy
Flexible sigmoidoscopy
Barium enema

❑ Computed tomographic colonography
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider the diagnostic criteria of constipation
Rome III criteria:[1][7]

Symptoms for ≥6 months and ≥2 of the following for the past 3 months:

❑ Straining during defecation
❑ Hard or lumpy stools
❑ Sensation of incomplete evacuation during defecation
❑ Sensation of anorectal obstruction/blockade during defecation
❑ Manual maneuvers to facilitate defecations with <3 defecations/week
❑ Absence of loose stools

Pharmacologic studies based criteria:[1][8]
Spontaneous bowel movements <3 per week and ≥1 of the following for at least 12 weeks during the past 12 months:

❑ Straining during more than one-fourth of defecation
❑ Lumpy or hard stools in more than one-fourth of defecation
❑ Sensation of incomplete evacuation in more than one-fourth of defecation
❑ Absence of loose stools or watery spontaneous bowel movements
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Adjust or discontinue medications causing constipation

❑ Administer a trial of fiber and/or osmotic or stimulant laxatives


If secondary causes of constipation are uncovered during evaluation:
Due to metabolic conditions, myopathies, neuropathies, or other conditions
❑ Treat the secondary cause
or
❑ Offer symptomatic treatment


If organic causes of constipation are uncovered during evaluation:
Due to mechanical obstruction or adverse drug effect
❑ Treat mechanical obstruction or remove the drug causing constipation
or
❑ Offer symptomatic treatment


If irritable bowel syndrome is diagnosed during evaluation:

❑ Treat irritable bowel syndrome
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adequate response to trial of fiber and/or laxatives
 
 
 
 
 
Inadequate response to trial of fiber and/or laxatives
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General management of constipation
 
 
 
 
 
❑ Gastroenterology consult
❑ Anorectal manometry
❑ Balloon expulsion test
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal
 
Inconclusive
 
Abnormal
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Barium defecography
or
❑ MR defecography
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal
 
Abnormal
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Colonic transit
 
 
 
Defecatory disorder
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Slow
 
Normal
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Slow transit constipation
 
Normal transit constipation
 
 
 
 
 
 
 
 
 
 

Therapeutic Approach

Shown below are algorithms depicting the general as well as clinical subgroups based therapeutic approaches of constipation in adults based on the American Gastroenterological Association (AGA) guideline.[1][6]

General Management

 
 
 
 
Constipation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start treatment with dietary fiber supplementation:

Psyllium: 1 tsp up to 3 times daily
or
Methylcellulose: 1 tsp up to 3 times daily
or
Calcium polycarbophil: 2-4 tablets OD


❑ Advice to take along with fluids and/or meals
❑ Gradually adjust the dose after 7 to 10 days
❑ Continue the adjusted dose for several weeks


❑ Advice increased fluid intake if dehydration is present

❑ Advice on increasing physical activity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If more treatment is needed:

Add hyperosmolar agents:
Polyethylene glycol: 8-32 oz OD

❑ 2 weeks to 24 months
❑ Polyethylene glycol with electrolyte containing preparation indicated when large volume is used for colonic cleansing

or
Lactulose: 15-30 ml OD or BID
or
Sorbitol 15-30 ml OD or BID


Supplement with stimulant laxatives as needed:
Bisacodyl

❑ 10 mg suppositories
or
❑ 5-10 mg orally up to 3 times/week

or
Glycerin: Suppository OD
Anthraquinones

❑ 2 tablets OD to 4 tablets BID
or
❑ 1-2 tsp once daily

❑ Administer suppositories 30 minutes after breakfast


If necessary administer:
❑ Pyridostigmine in type 2 diabetes mellitus patients with constipation
❑ Misoprostol

❑ Opioid antagonists in patients with opioid induced constipation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Normal and Slow Transit Constipation

 
 
 
 
Normal or slow transit constipation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Administer:

❑ Hyperosmolar agents

Polyethylene glycol: 8-32 oz OD

or
❑ Saline laxatives

Milk of magnesia: 15-30 mL OD or BID

or
❑ Stimulant laxatives

Bisacodyl
❑ 10 mg suppositories
or
❑ 5-10 mg orally up to 3 times/week
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient improves

❑ Continue the same regimen on a long term basis
 
Patient does not improve

❑ Modify the treatment regimen by considering

❑ Secretagogues
❑ Lubiprostone 24 μg BID
or
❑ Linaclotide 145 μg daily

or

❑ Serotonin 5-HT4 receptor agonists
❑ Prucalopridec
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient improves

❑ Continue the same regimen on a long term basis
 
Patient does not improve

❑ Repeat colonic transit test while continuing medications
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Delayed transit

❑ Consider gastric emptying
 
Normal transit

❑ Adjust medications as needed
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Slow emptying

❑ Consider assessment for upper GI motility disorder
 
 
 
Normal emptying
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abnormal

❑ Manage the upper GI motility disorder appropriately
 
Normal
 
Consider colonic manometry ± barostat
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal

❑ Consider temporary loop ileostomy
 
Abnormal

❑ Consider subtotal colectomy + ileorectal anastamosis
 
 
 
 
 
 

Defecatory disorder

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chronic constipation who have not responded to a high-fiber diet and/or over-the-counter laxatives after organic disorders have been excluded
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal BET, ARM, BD, CTT
 
Abnormal CTT
Normal BET, ARM, BD
 
Abnormal BET, ARM, BD
Normal CTT
 
Abnormal BET, ARM, BD, CTT
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal transit constipation
 
Slow transit constipation
 
Pelvic floor dysfunction
 
Combined slow transit constipation and pelvic floor dysfunction
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Pelvic Floor Dysfunction

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pelvic floor dysfunction
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abnormal BET or BD

❑ Define rectoanal angle
❑ Define preineal descent
❑ Define rectal emptying


High resting pressure


❑ Rule out anal fissure first


Abnormal reflex


❑ Absence of rectoanal inhibitory reflex

❑ Rule out adult Hirschsprung's disease
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fiber

Psyllium: 1 tsp up to 3 times daily
OR
Methylcellulose: 1 tsp up to 3 times daily


PLUS


Stimulant laxative


Bisacodyl: 10 mg suppositories or 5-10 mg orally up to 3 times/wk
OR

Glycerin: Suppository OD
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biofeedback

❑ Anorectal and pelvic floor muscle activity are recorded by surface electromyographic sensors
❑ Patients are taught to increase intraabdominal pressure and relax the pelvic floor muscles during defecation
❑ Patients practice by expelling an air filled balloon or through external traction to a catheter attached to the balloon
❑ Patients are taught to recognize weaker sensations of rectal filling
❑ Patients are taught Kegel exercises

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Response to treatment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Follow clinically
 
 
 
Repeat balloon expulsion test
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abnormal
 
 
 
Normal
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform defecating proctogram
 
 
 
Manage as normal transit constipation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal
 
 
 
Abnormal
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reassess biofeedback + medications if needed
 
 
 
Define anatomic rectal defect
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No response
 
Clinically significant
 
 
Insignificant
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider surgery
 
Surgical repair and follow up
 
 
No surgery needed
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Combined Pelvic Floor Dysfunction and Slow Transit Constipation

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Combined pelvic floor dysfunction and slow transit constipation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biofeedback

PLUS


Dietary fiber: Psyllium/methylcellulose


PLUS


Stimulant laxative: Bisacodyl


PLUS


Saline laxative: Milk of magnesia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Response to treatment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform colonic transit test without medications
 
 
 
 
 
 
Repeat balloon expulsion test
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If delayed manage as slow transit constipation
 
 
If normal follow clinically
 
Abnormal
 
 
 
Normal
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform defecating proctogram
 
 
 
Manage as slow transit constipation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal
 
 
 
 
 
Abnormal
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reassess biofeedback + add hyperosmolar agents (lactulose/PEG)
 
 
 
 
 
Define anatomic rectal defect
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No improvement
 
 
 
No response
 
Clinically significant
 
 
Insignificant
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Repeat colonic transit test on medications
 
 
 
Continue therapeutic regimen
 
Surgical repair and follow up
 
 
No surgery needed
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal
 
Delayed
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjust medications as needed
 
Consider surgery
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider surgery if no improvement
 
 
 
 
 
 

Do's

  • Do begin evaluation of constipation with a detailed history and physical examination that includes a rectal examination.
  • Do perform a colonoscopy in patient's presenting with the recent onset of constipation without an obvious explanation, hematochezia, weight loss of ≥10 pounds, a family history of colon cancer or inflammatory bowel disease, anemia and positive fecal occult blood test.
  • Do perform a trial of conservative management of lifestyle and dietary modification in patients without any of the above alarm symptoms.

Dont's

  • Dont use insoluble fiber like wheat bran for the intial managment of constipation in adults.

References

  1. 1.0 1.1 1.2 1.3 1.4 Bharucha AE, Pemberton JH, Locke GR (2013). "American Gastroenterological Association technical review on constipation". Gastroenterology. 144 (1): 218–38. doi:10.1053/j.gastro.2012.10.028. PMC 3531555. PMID 23261065.
  2. American College of Gastroenterology Chronic Constipation Task Force (2005). "An evidence-based approach to the management of chronic constipation in North America". Am J Gastroenterol. 100 Suppl 1: S1–4. doi:10.1111/j.1572-0241.2005.50613_1.x. PMID 16008640.
  3. Locke GR, Pemberton JH, Phillips SF (2000). "American Gastroenterological Association Medical Position Statement: guidelines on constipation". Gastroenterology. 119 (6): 1761–6. PMID 11113098.
  4. Caldarella MP, Milano A, Laterza F; et al. (2005). "Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion". Am. J. Gastroenterol. 100 (2): 383–9. doi:10.1111/j.1572-0241.2005.40100.x. PMID 15667496.
  5. "Nicotine withdrawal symptoms:Constipation". helpwithsmoking.com. 2005. Retrieved 2007-06-29.
  6. 6.0 6.1 Bharucha, AE.; Dorn, SD.; Lembo, A.; Pressman, A. (2013). "American Gastroenterological Association medical position statement on constipation". Gastroenterology. 144 (1): 211–7. doi:10.1053/j.gastro.2012.10.029. PMID 23261064. Unknown parameter |month= ignored (help)
  7. Longstreth, GF.; Thompson, WG.; Chey, WD.; Houghton, LA.; Mearin, F.; Spiller, RC. (2006). "Functional bowel disorders". Gastroenterology. 130 (5): 1480–91. doi:10.1053/j.gastro.2005.11.061. PMID 16678561. Unknown parameter |month= ignored (help)
  8. Lembo, AJ.; Kurtz, CB.; Macdougall, JE.; Lavins, BJ.; Currie, MG.; Fitch, DA.; Jeglinski, BI.; Johnston, JM. (2010). "Efficacy of linaclotide for patients with chronic constipation". Gastroenterology. 138 (3): 886–95.e1. doi:10.1053/j.gastro.2009.12.050. PMID 20045700. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources